{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:17Z","timestamp":1759334837757,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jaad.2017.09.015","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T12:02:22Z","timestamp":1510315342000},"page":"530-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study"],"prefix":"10.1016","volume":"78","author":[{"given":"Shay","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenal","family":"Kheterpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia L.","family":"Myskowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa P.","family":"Pulitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.jaad.2017.09.015_bib1","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jaad.2017.09.015_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.jaad.2017.09.015_bib3","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.09.015_bib4","unstructured":"National Cancer Institute. Pembrolizumab in treating patients with relapsed or refractory stage IB-IVB mycosis fungoides or Sezary syndrome. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT02243579. Accessed March 5, 2017."},{"issue":"7528","key":"10.1016\/j.jaad.2017.09.015_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.jaad.2017.09.015_bib6","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jaad.2017.09.015_bib7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U","article-title":"Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma","volume":"91","author":"Smyrk","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.09.015_bib8","unstructured":"Mesinkovska N, Ko J. Worse outcome in melanoma patients recently pregnant: decreased T-cell programmed death receptor-1 (PD-1) expression in primary tumors suggests immune ignorance. Oral presentation at: 51st Annual Meeting of the American Society of Dermatopathology. November 6, 2014; Chicago, IL."},{"issue":"2","key":"10.1016\/j.jaad.2017.09.015_bib9","doi-asserted-by":"crossref","first-page":"e984547","DOI":"10.4161\/2162402X.2014.984547","article-title":"The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review","volume":"4","author":"Punt","year":"2015","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.jaad.2017.09.015_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4049\/jimmunol.1002807","article-title":"Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic Simian immunodeficiency virus infection","volume":"186","author":"Nigam","year":"2011","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jaad.2017.09.015_bib11","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jaad.2017.09.015_bib12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jaad.2017.09.015_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","article-title":"Differential expression of programmed death-1 (PD-1) in Sezary syndrome and mycosis fungoides","volume":"148","author":"Cetin\u00f6zman","year":"2012","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.015_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajh.21960","article-title":"Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sezary syndrome","volume":"86","author":"Wada","year":"2011","journal-title":"Am J Hematol"},{"issue":"22","key":"10.1016\/j.jaad.2017.09.015_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V128.22.181.181","article-title":"Pembrolizumab for treatment of relapsed\/refractory mycosis fungoides and Sezary syndrome: clinical efficacy in a citn multicenter phase 2 study","volume":"128","author":"Khodadoust","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.015_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","article-title":"CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides","volume":"32","author":"Hoppe","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"23","key":"10.1016\/j.jaad.2017.09.015_bib17","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1200\/JCO.2001.19.23.4322","article-title":"CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas ligand, and killing inhibitory receptors and their relationship with clinical behavior","volume":"19","author":"Vermeer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.09.015_bib18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1749-6632.1976.tb41664.x","article-title":"Immunocompetence, immunodeficiency and prognosis in cancer","volume":"276","author":"Hersh","year":"1976","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jaad.2017.09.015_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(95)70491-4","article-title":"Cancer in children with primary or secondary immunodeficiencies","volume":"126","author":"Mueller","year":"1995","journal-title":"J Pediatr"},{"issue":"23","key":"10.1016\/j.jaad.2017.09.015_bib20","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/jnci\/85.23.1932","article-title":"Second cancers among long-term survivors of non-Hodgkin's lymphoma","volume":"85","author":"Travis","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.jaad.2017.09.015_bib21","first-page":"443","article-title":"Effect of pregnancy upon malignant melanoma","volume":"157","author":"Sutherland","year":"1983","journal-title":"Surg Gynecol Obstet"},{"issue":"21","key":"10.1016\/j.jaad.2017.09.015_bib22","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.2004.02.096","article-title":"Effect of pregnancy on survival in women with cutaneous malignant melanoma","volume":"22","author":"Lens","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2017.09.015_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<304::AID-CNCR18>3.0.CO;2-#","article-title":"Pregnancy-associated lymphomas. A clinicopathologic study","volume":"78","author":"Gelb","year":"1996","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2017.09.015_bib24","doi-asserted-by":"crossref","first-page":"e35178","DOI":"10.1371\/journal.pone.0035178","article-title":"Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia","volume":"7","author":"Grzywnowicz","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaad.2017.09.015_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3324\/haematol.2012.077537","article-title":"The PD-1\/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia","volume":"98","author":"Brusa","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jaad.2017.09.015_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J Exp Med"},{"issue":"1-2","key":"10.1016\/j.jaad.2017.09.015_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jri.2008.12.001","article-title":"Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy","volume":"80","author":"Taglauer","year":"2009","journal-title":"J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.015_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/leu.2011.237","article-title":"Regulatory T cells and immunodeficiency in mycosis fungoides and Sezary syndrome","volume":"26","author":"Krejsgaard","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jaad.2017.09.015_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajpath.2012.08.041","article-title":"The role and regulation of human Th17 cells in tumor immunity","volume":"182","author":"Ye","year":"2013","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2017.09.015_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ijc.20373","article-title":"Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome)","volume":"112","author":"Cir\u00e9e","year":"2004","journal-title":"Int J Cancer"},{"issue":"24","key":"10.1016\/j.jaad.2017.09.015_bib31","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-11-1192","article-title":"IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma","volume":"17","author":"Miyagaki","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.015_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1078-0432.CCR-07-0610","article-title":"Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma\/mycosis fungoides","volume":"14","author":"Chong","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:23Z","timestamp":1759272323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217323393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0190962217323393"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.015","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}